Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FSG67
Cat. No.:
OB0425LY-039
Appearance:
Solid
Purity:
99.89%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
FSG67 is a high-quality inhibitor of glycerol 3-phosphate acyltransferase (GPAT).
Synonyms:
2-(Nonylsulfonamido)benzoic acid; 1158383-34-6; 2-(Nonylsulfonamido)benzoicacid; 2-(Nonylsulfonamido) benzoic acid
CAS No.:
1158383-34-6
Compound CID:
44139871
Formula:
C16H25NO4S
Formula Weight:
327.44
Specification
Target:
Acyltransferase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
FSG67 can be used for research on metabolic diseases such as obesity.
